We recently published a list of Jim Cramer’s List of 16 Stocks to Buy Right Now. In this article, we are going to take a look ...

We recently published a list of Jim Cramer is Bullish on These 10 Stocks. In this article, we are going to take a look at ...

The global healthcare supply chain management market, valued at USD 2.2 billion in 2021, is poised to grow at a robust CAGR of 13.2% through 2028, reaching approximately USD 5.3 billion. This growth ...

In this article, we are going to take a look at where McKesson Corporation (NYSE:MCK) stands against other best value dividend stocks. Dividends, though sometimes underappreciated, have ...

North America: Leading the global market, North America benefits from extensive R&D investments and a mature pharmaceutical sector. The region’s high prevalence of chronic diseases, such as cancer, ...

Recognizing the critical role genomic testing and targeted therapies play today in providing high-quality cancer treatment, McKesson has launched a transformative initiative that will address the ...

$40,000 of MCKESSON CORPORATION lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Issues related to the pharmaceutical ...

In this article, we are going to take a look at where McKesson Corporation (NYSE:MCK) stands against other stocks that Jim Cramer discussed. On Thursday, Jim Cramer, host of Mad Money, described ...

The healthcare claims management market is expected to expand at a CAGR of ~5% during the forecast period. Key growth drivers ...

Discover the top 10 S&P 500 stocks outperforming the market by trading well above their 200-day moving averages.

The Healthcare Analytics Market is expected to expand at a CAGR of ~20% during the forecast period. Key factors driving this ...